ICU sedation, delirium & recovery

Critically ill metastatic cancer patients returning home after unplanned ICU stay: an observational, multicentre retrospective study

Ann Intensive CarePublished Retrospective cohort study

Authors' conclusion

More than one out of three metastatic cancer patients could return home within 3 months after an unplanned admission to the ICU. Previous performance and nutritional status, ongoing specific treatment and low severity of the acute illness were found to be predictive for return home.

Study context

Population
Consecutive metastatic cancer patients (mainly lung cancer) with unplanned ICU admission, 2017–2020
Participants
253 patients
Outcome
Return home
Follow-up
Day 90
Methodological detailsmulticentre, observational
  • Multicentre
  • Observational

Main finding

As reported in the abstract

Return home on day 90

Metastatic cancer patients

37.2%

94 events

Predictive for 90-day return home
Odds ratio (95% CI)P value
Performance status 0 or 1
2.18(1.21–3.93)
P = 0.010
No malnutrition
2.90(1.61–5.24)
P < 0.001
Female gender
2.39(1.33–4.29)
P = 0.004
Recent chemotherapy
2.62(1.40–4.90)
P = 0.003
SOFA score ≤ 5 on admission
2.62(1.41–4.90)
P = 0.002

Observational data: associations, not effects.

Further findings

1-year mortality (independent associations)

HR (95% CI)P value
Malnutrition1.66 (1.18–2.22)P = 0.003
ARF as reason for admission1.40 (1.10–1.95)P = 0.043
SAPS II on admission1.03 (1.02–1.05)P < 0.001
DFLSTDecisions to forgo life-sustaining therapies2.80 (2.04–3.84)P < 0.001

1-year survival

One-year survival rate
28.5%

Original publication

Critically ill metastatic cancer patients returning home after unplanned ICU stay: an observational, multicentre retrospective study. Ann Intensive Care. Published 21 August 2023. doi:10.1186/s13613-023-01170-5

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.